Literature DB >> 804443

Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.

L Levy, H Ng, M J Evans, J L Krahenbuhl.   

Abstract

B6C3F1 mice that had been thymectomized at 8 to 12 weeks of age, subjected to 950 R of whole-body X irradiation, and transfused with syngeneic bone marrow were challenged in a footpad with Mycobacterium leprae or M. marinum, or intravenously or intraperitioneally with Listeria monocytogenes. Also, mice inoculated with M. leprae in a hind footpad were administered dapsone in the mouse chow. The thymectomized-irradiated (T + R) mice did not survive as well as non-thymectomized mice when housed in the vivarium with no special precautions, but survived sufficiently well to permit the completion of some long-term experiments. M. leprae multiplied to a higher "ceiling" and survived longer in the T + R mice than in the non-thymectomized controls. But a ceiling to multiplication of M. leprae was imposed, and finally the organisms were killed. The histopathological appearance of the footpad tissues, studied by electron microscopy, was consistent with the measurements of bacterial numbers and viability. Swelling of the footpad after local inoculation with M. marinum was greater in T + R mice than in non-thymectomized controls. Similarly, the number of L. monocytogenes following intravenous challenge was greater in the spleens of T + R than of non-thymectomized mice, and the survival of the T + R mice was impaired after intraperitoneal challenge with L.monocytogenes, compared to the survival of non-thymectomized mice. None of these differences was striking, suggesting that these T + R mice had retained or regained some immune competence. The effects of dapsone treatment of T + R mice inoculated with M. leprae were much the same as those of treatment of non-thymectomized mice. Because these T + R mice were not greatly immunosuppressed, they would not have provided a model of human lepromatous leprosy suitable for chemotherapeutic studies.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804443      PMCID: PMC415187          DOI: 10.1128/iai.11.5.1122-1132.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  The use of survival time in the analysis of neutralization tests for serum antibody surveys.

Authors:  C E G SMITH; D R WESTGARTH
Journal:  J Hyg (Lond)       Date:  1957-06

2.  Studies of the mouse foot pad technic for cultivation of Mycobacterium leprae. 1. Fate of inoculated organisms.

Authors:  L Levy; N Moon; L P Murray; S M O'Neill; L E Gustafson; M J Evans
Journal:  Int J Lepr Other Mycobact Dis       Date:  1974 Apr-Jun

3.  Prolongation of the lag phase of Mycobacterium leprae by dapsone.

Authors:  L Levy
Journal:  Proc Soc Exp Biol Med       Date:  1972-01

4.  Pharmacologic studies of clofazimine.

Authors:  L Levy
Journal:  Am J Trop Med Hyg       Date:  1974-11       Impact factor: 2.345

5.  The effect of freezing and storage at -60 degrees C on the viability of Mycobacterium leprae.

Authors:  L Levy
Journal:  Cryobiology       Date:  1971-12       Impact factor: 2.487

6.  The death rate of Mycobacterium leprae during treatment of lepromatous leprosy with acedapsone (DADDS).

Authors:  C C Shepard; L Levy; P Fasal
Journal:  Am J Trop Med Hyg       Date:  1972-07       Impact factor: 2.345

Review 7.  The first decade in experimental leprosy.

Authors:  C C Shepard
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Early response of mouse foot pads to Mycobacterium laprae.

Authors:  M J Evans; H E Newton; L Levy
Journal:  Infect Immun       Date:  1973-01       Impact factor: 3.441

9.  Ultrastructural changes in cells of the mouse footpad infected with Mycobacterium leprae.

Authors:  M J Evans; L Levy
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

10.  Analogy of Mycobacterium marinum disease to Mycobacterium leprae infection in footpads of mice.

Authors:  H Ng; P L Jacobsen; L Levy
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

View more
  6 in total

Review 1.  Immunocompetent cells in resistance to bacterial infections.

Authors:  P A Campbell
Journal:  Bacteriol Rev       Date:  1976-06

2.  Mycobacterium leprae surface components intervene in the early phagosome-lysosome fusion inhibition event.

Authors:  C Frehel; N Rastogi
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

4.  Effect of levamisole on Mycobacterium leprae in mice.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

5.  Intracellular location of Mycobacterium leprae in macrophages of normal and immune-deficient mice and effect of rifampin.

Authors:  N Mor
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

6.  World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.

Authors:  Maria Lazo-Porras; Gabriela J Prutsky; Patricia Barrionuevo; Jose Carlos Tapia; Cesar Ugarte-Gil; Oscar J Ponce; Ana Acuña-Villaorduña; Juan Pablo Domecq; Celso De la Cruz-Luque; Larry J Prokop; Germán Málaga
Journal:  BMC Infect Dis       Date:  2020-01-20       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.